# |
|
Family |
MCID |
Name |
MIFTS |
Score |
1 |
|
|
MYL009 |
Myelodysplastic Syndrome |
67 |
19.065 |
|
2 |
|
|
MCR017 |
Macrocytic Anemia |
44 |
14.271 |
|
3 |
|
P
|
HLP001 |
Holoprosencephaly |
69 |
12.815 |
|
4 |
|
c
|
LKM061 |
Leukemia, Acute Myeloid |
83 |
11.879 |
|
5 |
|
c
|
FNC027 |
Fanconi Anemia, Complementation Group a |
81 |
11.839 |
|
6 |
|
c
|
HLP023 |
Holoprosencephaly 1 |
56 |
9.551 |
|
7 |
|
P
|
HRT032 |
Heart Disease |
81 |
9.551 |
|
8 |
|
|
ATY042 |
Atypical Chronic Myeloid Leukemia |
50 |
8.574 |
|
9 |
|
P
|
MLN069 |
Melanoma, Uveal |
61 |
7.882 |
|
10 |
|
c
|
MCR240 |
Microcephalic Osteodysplastic Primordial Dwarfism, Type I |
54 |
7.882 |
|
11 |
|
c
|
CHR418 |
Chronic Leukemia |
48 |
7.882 |
|
12 |
|
|
MYL075 |
Myelodysplastic/myeloproliferative Neoplasm |
51 |
7.882 |
|
13 |
|
|
DND022 |
Dendritic Cell Deficiency |
23 |
7.882 |
|
14 |
|
P
|
MYL006 |
Myeloid Leukemia |
61 |
3.415 |
|
15 |
|
P
|
PRS040 |
Prostate Cancer |
95 |
2.817 |
|
16 |
|
c
|
ACT073 |
Acute Leukemia |
58 |
2.656 |
|
17 |
|
|
DFC004 |
Deficiency Anemia |
74 |
2.520 |
|
18 |
|
P
|
THR014 |
Thrombocytopenia |
66 |
2.520 |
|
19 |
|
P
|
NTR004 |
Neutropenia |
63 |
2.373 |
|
20 |
|
|
DWN001 |
Down Syndrome |
70 |
2.209 |
|
21 |
|
P
|
CHR285 |
Chronic Myelomonocytic Leukemia |
60 |
1.831 |
|
22 |
|
|
DND018 |
Dendritic Cell Tumor |
41 |
1.804 |
|
23 |
|
|
BLS007 |
Blastic Plasmacytoid Dendritic Cell |
38 |
1.804 |
|
24 |
|
|
HRT038 |
Heart, Malformation of |
36 |
1.669 |
|
25 |
|
P
|
LKM002 |
Leukemia |
67 |
1.384 |
|
26 |
|
|
THR004 |
Thrombocytosis |
53 |
1.384 |
|
27 |
|
|
CHR178 |
Chromosomal Triplication |
34 |
1.384 |
|
28 |
|
P
|
LKM062 |
Leukemia, Acute Lymphoblastic |
69 |
1.294 |
|
29 |
|
P
|
LKM071 |
Leukemia, Chronic Lymphocytic |
75 |
1.199 |
|
30 |
|
P
|
TMR010 |
Tumor Predisposition Syndrome |
67 |
0.988 |
|
31 |
|
|
RFR010 |
Refractory Anemia |
49 |
0.979 |
|
32 |
|
c
|
LKM063 |
Leukemia, Chronic Myeloid |
71 |
0.979 |
|
33 |
|
P
|
APL001 |
Aplastic Anemia |
73 |
0.979 |
|
34 |
|
c
|
FNC028 |
Fanconi Anemia, Complementation Group L |
46 |
0.979 |
|
35 |
|
P
|
PLM175 |
Pulmonary Fibrosis and/or Bone Marrow Failure, Telomere-Related, 2 |
51 |
0.979 |
|
36 |
|
|
PRC049 |
Precursor T-Cell Acute Lymphoblastic Leukemia |
45 |
0.692 |
|
37 |
|
|
ACT098 |
Acute Erythroid Leukemia |
55 |
0.692 |
|
38 |
|
|
CRB138 |
Core Binding Factor Acute Myeloid Leukemia |
45 |
0.692 |
|
39 |
|
|
MYL005 |
Myelofibrosis |
71 |
0.692 |
|
40 |
|
|
PLY001 |
Polycythemia Vera |
69 |
0.692 |
|
41 |
|
c
|
EXS020 |
Exostoses, Multiple, Type Ii |
38 |
0.692 |
|
42 |
|
|
CHR635 |
Chromosome 5q Deletion Syndrome |
50 |
0.692 |
|
43 |
|
|
JVN004 |
Juvenile Myelomonocytic Leukemia |
67 |
0.692 |
|
44 |
|
|
THY029 |
Thyroid Carcinoma |
51 |
0.692 |
|
45 |
|
|
CHR286 |
Chronic Neutrophilic Leukemia |
43 |
0.692 |
|
46 |
|
|
SYS004 |
Systemic Mastocytosis |
63 |
0.692 |
|
47 |
|
P
|
MST009 |
Mastocytosis |
64 |
0.692 |
|
48 |
|
P
|
PLY018 |
Polycythemia |
56 |
0.692 |
|
49 |
|
|
HLX001 |
Helix Syndrome |
48 |
0.692 |
|
50 |
|
P
|
ESS003 |
Essential Thrombocythemia |
69 |
0.692 |
|
51 |
|
|
MYL031 |
Myeloproliferative Neoplasm |
66 |
0.692 |
|
52 |
|
P
|
ADN016 |
Adenocarcinoma |
63 |
0.692 |
|
53 |
|
|
TCL027 |
T-Cell Acute Lymphoblastic Leukemia |
51 |
0.692 |
|
54 |
|
|
PRP030 |
Purpura |
54 |
0.692 |
|
55 |
|
c
|
THR001 |
Thrombocytopenia Due to Platelet Alloimmunization |
60 |
0.692 |
|
56 |
|
P
|
NRF002 |
Neurofibromatosis |
57 |
0.692 |
|
57 |
|
c
|
GLM047 |
Glioma Susceptibility 3 |
33 |
0.663 |
|
58 |
|
c
|
MSM022 |
Mismatch Repair Cancer Syndrome 1 |
70 |
0.663 |
|
59 |
|
c
|
GLM025 |
Glioma Susceptibility 2 |
30 |
0.663 |
|
60 |
|
c
|
GLM043 |
Glioma Susceptibility 9 |
30 |
0.663 |
|
61 |
|
|
GST103 |
Gastric Cancer, Hereditary Diffuse |
68 |
0.663 |
|
62 |
|
P
|
GLM040 |
Glioma Susceptibility 1 |
71 |
0.663 |
|
63 |
|
|
MNN043 |
Meningioma, Familial |
79 |
0.663 |
|
64 |
|
P
|
OLG002 |
Oligodendroglioma |
66 |
0.663 |
|
65 |
|
|
BRS099 |
Breast Ductal Carcinoma |
61 |
0.663 |
|
66 |
|
|
GLM045 |
Glioma |
63 |
0.663 |
|
67 |
|
P
|
PNC035 |
Pancreatic Cancer |
86 |
0.602 |
|
68 |
|
|
END057 |
Endometrial Cancer |
72 |
0.593 |
|
69 |
|
|
SML009 |
Small Intestine Adenocarcinoma |
57 |
0.593 |
|
70 |
|
|
SML031 |
Small Cell Carcinoma of the Bladder |
46 |
0.513 |
|
71 |
|
c
|
PLY162 |
Polyposis Syndrome, Hereditary Mixed, 1 |
60 |
0.513 |
|
72 |
|
c
|
CLR087 |
Colorectal Cancer 12 |
34 |
0.513 |
|
73 |
|
|
END041 |
Endometrial Adenocarcinoma |
64 |
0.513 |
|
74 |
|
P
|
BLD134 |
Bladder Cancer |
79 |
0.419 |
|
75 |
|
P
|
GST053 |
Gastric Cancer |
83 |
0.419 |
|
76 |
|
|
CLN015 |
Colon Adenocarcinoma |
65 |
0.419 |
|
77 |
|
P
|
LNG032 |
Lung Cancer |
98 |
0.296 |
|
78 |
|
|
IRN008 |
Iron Overload in Africa |
51 |
0.296 |
|
79 |
|
c
|
CHL136 |
Cholestasis, Progressive Familial Intrahepatic, 2 |
57 |
0.296 |
|
80 |
|
P
|
BRS047 |
Breast Cancer |
98 |
0.296 |
|
81 |
|
|
LNG111 |
Lung Non-Squamous Non-Small Cell Carcinoma |
56 |
0.296 |
|
82 |
|
|
HPT079 |
Hepatoid Adenocarcinoma |
39 |
0.296 |
|
83 |
|
|
NNL005 |
Non-Alcoholic Fatty Liver Disease |
63 |
0.296 |
|
84 |
|
|
RJS001 |
Ruijs-Aalfs Syndrome |
47 |
0.296 |
|
85 |
|
c
|
HPT073 |
Hepatitis C Virus |
71 |
0.296 |
|
86 |
|
P
|
HPT023 |
Hepatocellular Carcinoma |
96 |
0.296 |
|
87 |
|
|
ADN011 |
Adenoid Cystic Carcinoma |
68 |
0.296 |
|
88 |
|
|
PDT042 |
Pediatric Hepatocellular Carcinoma |
49 |
0.296 |
|
89 |
|
P
|
BLD062 |
Bile Duct Cancer |
67 |
0.296 |
|
90 |
|
P
|
LNG021 |
Lung Occult Small Cell Carcinoma |
20 |
0.296 |
|
91 |
|
|
LNG019 |
Lung Combined Type Small Cell Carcinoma |
32 |
0.296 |
|
92 |
|
|
GST040 |
Gastric Adenocarcinoma |
67 |
0.296 |
|
93 |
|
|
LNG039 |
Lung Squamous Cell Carcinoma |
57 |
0.296 |
|
94 |
|
|
ADN089 |
Adenosquamous Lung Carcinoma |
49 |
0.296 |
|
95 |
|
P
|
LNG064 |
Lung Cancer Susceptibility 3 |
70 |
0.296 |
|
96 |
|
c
|
PRG047 |
Progressive Familial Intrahepatic Cholestasis |
64 |
0.296 |
|
97 |
|
|
ADL096 |
Adult Hepatocellular Carcinoma |
60 |
0.296 |
|
98 |
|
|
BRN015 |
Bronchiolo-Alveolar Adenocarcinoma |
55 |
0.296 |
|
99 |
|
|
FBR086 |
Fibrolamellar Carcinoma |
59 |
0.296 |
|
100 |
|
|
HPT011 |
Hepatocellular Clear Cell Carcinoma |
46 |
0.296 |
|
101 |
|
|
LBL001 |
Lobular Neoplasia |
55 |
0.296 |
|
102 |
|
|
PTY007 |
Pityriasis Rotunda |
26 |
0.296 |
|